SI-BONE Receives FDA Clearance for iFuse-3D
SI-BONE received FDA 510(k) clearance and commenced full U.S. launch of the iFuse-3D™ Implant. Jun 13, 2017
Vertera Spine Receives CMS ICD-10 Code for COHERE Cervical Interbody Fusion Device
CMS issued a new ICD-10 code for a radiolucent porous interbody fusion device, supporting Vertera Spine’s COHERE cervical device. Jun 13, 2017
Clinical Trial for New Indication of DJO Bone Growth Stimulators
DJO Global announced a clinical trial for a fresh fracture indication with the CMF OL1000™ Bone Growth Stimulator. Jun 13, 2017
FDA Closes Warning Letter for Zimmer Biomet China Facility
FDA notified Zimmer Biomet that a Warning Letter dated June 3, 2015 relating to its Zhejiang, China manufacturing facility has been closed out. Jun 13, 2017
First Procedures with Exactech’s Alteon HA Femoral Hip Stem
Exactech completed initial surgeries with the Alteon® HA Femoral Hip stem. Jun 12, 2017
Vertos Medical Completes $28 Million Financing Round
Vertos Medical completed a US $28MM financing round. Funds will support commercialization of the mild® outpatient procedure for the minimally invasive treatment of stenosis. Jun 12, 2017
Carevature Medical’s First US Cervical Decompressions
Carevature Medical announced initial U.S. cases using the Dreal™ system for cervical spinal decompression. Jun 12, 2017
Extremity Medical Launches BioFuse Viable Cell Bone Graft
Extremity Medical launched BioFuse, a next-gen viable cell bone graft for use in the foot, ankle, wrist and hand. Jun 09, 2017
Amedica: 2016 Preliminary Results and Business Update
Amedica announced preliminary 2016 revenue of US $15.2MM, -22.2% vs. 2015, and 4Q16 revenue of $3.6MM, -30.5% vs. 4Q15. Jun 09, 2017
Bone Therapeutics Completes Recruitment in PREOB Phase III Trial
Bone Therapeutics completed patient recruitment for interim analysis in its Phase III trial of PREOB® for the treatment of hip osteonecrosis. Jun 08, 2017
